Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy
<p>Abstract</p> <p>Individualized therapies that are tailored to a patient's genetic composition will be of tremendous value for treatment of cancer. Recently, Kirsten <it>ras </it>(KRAS) status has emerged as a predictor of response to epidermal growth factor rece...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-04-01
|
| Series: | Journal of Hematology & Oncology |
| Online Access: | http://www.jhoonline.org/content/2/1/18 |